CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,309,000 | -65.5% | 587,626 | +30.6% | 1.28% | -62.0% |
| Q2 2019 | $6,692,000 | +8.1% | 450,000 | +80.4% | 3.37% | +24.6% |
| Q1 2019 | $6,190,000 | +473.7% | 249,389 | +315.0% | 2.71% | +386.2% |
| Q4 2018 | $1,079,000 | -55.6% | 60,100 | +30.6% | 0.56% | -63.4% |
| Q1 2018 | $2,429,000 | -10.7% | 46,001 | +15.0% | 1.52% | -23.8% |
| Q4 2017 | $2,720,000 | – | 40,000 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |